Sudo, T., Utsunomiya, T., Mimori, K., Nagahara, H., Ogawa, K., Inoue, H., . . . Mori, M. (2005). Clinicopathological significance of EZH2 mRNA expression in patients with hepatocellular carcinoma. Nature Publishing Group.
Styl ChicagoSudo, T., et al. Clinicopathological Significance of EZH2 MRNA Expression in Patients With Hepatocellular Carcinoma. Nature Publishing Group, 2005.
Citace podle MLASudo, T., et al. Clinicopathological Significance of EZH2 MRNA Expression in Patients With Hepatocellular Carcinoma. Nature Publishing Group, 2005.
Upozornění: Tyto citace jsou generovány automaticky. Nemusí být zcela správně podle citačních pravidel..